Search details
1.
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
N Engl J Med
; 384(5): 403-416, 2021 02 04.
Article
in English
| MEDLINE | ID: mdl-33378609
2.
Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.
J Infect Dis
; 228(12): 1662-1666, 2023 12 20.
Article
in English
| MEDLINE | ID: mdl-37561027
3.
Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial.
Clin Infect Dis
; 77(4): 560-564, 2023 08 22.
Article
in English
| MEDLINE | ID: mdl-37036397
4.
Controlled Infection of Humans with the Hookworm Parasite Necator americanus to Accelerate Vaccine Development : The Human Hookworm Vaccination/Challenge Model (HVCM).
Curr Top Microbiol Immunol
; 2021 Jul 31.
Article
in English
| MEDLINE | ID: mdl-34328562
5.
Assessing the Dissemination of COVID-19 Articles Across Social Media With Altmetric and PlumX Metrics: Correlational Study.
J Med Internet Res
; 23(1): e21408, 2021 01 14.
Article
in English
| MEDLINE | ID: mdl-33406049
6.
Retraction: "Assessing the Dissemination of COVID-19 Articles Across Social Media With Altmetric and PlumX Metrics: Correlational Study".
J Med Internet Res
; 24(8): e41544, 2022 08 10.
Article
in English
| MEDLINE | ID: mdl-35947853
7.
Impact of gender on the decision to participate in a clinical trial: a cross-sectional study.
BMC Public Health
; 14: 1156, 2014 Nov 06.
Article
in English
| MEDLINE | ID: mdl-25377601
8.
Safety and immunogenicity of the co-administered Na-APR-1 and Na-GST-1 hookworm vaccines in school-aged children in Gabon: a randomised, controlled, observer-blind, phase 1, dose-escalation trial.
Lancet Infect Dis
; 2024 Mar 18.
Article
in English
| MEDLINE | ID: mdl-38513684
9.
Human immunoglobulin gene allelic variation impacts germline-targeting vaccine priming.
NPJ Vaccines
; 9(1): 58, 2024 Mar 11.
Article
in English
| MEDLINE | ID: mdl-38467663
10.
Serum CCL11 (eotaxin-1) and CCL17 (TARC) are serological indicators of multiple helminth infections and are driven by Schistosoma mansoni infection in humans.
Trop Med Int Health
; 18(6): 750-60, 2013 Jun.
Article
in English
| MEDLINE | ID: mdl-23496801
11.
Generalized urticaria induced by the Na-ASP-2 hookworm vaccine: implications for the development of vaccines against helminths.
J Allergy Clin Immunol
; 130(1): 169-76.e6, 2012 Jul.
Article
in English
| MEDLINE | ID: mdl-22633322
12.
Molecular mechanisms of hookworm disease: stealth, virulence, and vaccines.
J Allergy Clin Immunol
; 130(1): 13-21, 2012 Jul.
Article
in English
| MEDLINE | ID: mdl-22742835
13.
Assessment of the Dissemination of COVID-19-Related Articles Across Social Media: Altmetrics Study.
JMIR Form Res
; 7: e41388, 2023 Jul 12.
Article
in English
| MEDLINE | ID: mdl-37343075
14.
Vaccine value profile for Hookworm.
Vaccine
; 2023 Oct 18.
Article
in English
| MEDLINE | ID: mdl-37863671
15.
Prostate cancer cell-platelet bidirectional signaling promotes calcium mobilization, invasion and apoptotic resistance via distinct receptor-ligand pairs.
Sci Rep
; 13(1): 2864, 2023 02 17.
Article
in English
| MEDLINE | ID: mdl-36806315
16.
A randomized, controlled Phase 1b trial of the Sm-TSP-2 Vaccine for intestinal schistosomiasis in healthy Brazilian adults living in an endemic area.
PLoS Negl Trop Dis
; 17(3): e0011236, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36996185
17.
A first-in-human germline-targeting HIV nanoparticle vaccine induced broad and publicly targeted helper T cell responses.
Sci Transl Med
; 15(697): eadf3309, 2023 05 24.
Article
in English
| MEDLINE | ID: mdl-37224227
18.
Ultrasound-guided lymph node fine-needle aspiration for evaluating post-vaccination germinal center responses in humans.
STAR Protoc
; 4(4): 102576, 2023 Dec 15.
Article
in English
| MEDLINE | ID: mdl-37733596
19.
Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group study.
EClinicalMedicine
; 62: 102109, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-37533419
20.
Human immunoglobulin gene allelic variation impacts germline-targeting vaccine priming.
medRxiv
; 2023 Mar 15.
Article
in English
| MEDLINE | ID: mdl-36993183